Cargando…
血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295620/ https://www.ncbi.nlm.nih.gov/pubmed/34384163 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.016 |
_version_ | 1783725469365960704 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8295620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-82956202021-08-23 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2021-06 /pmc/articles/PMC8295620/ /pubmed/34384163 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.016 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
spellingShingle | 病例报告 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
title | 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
title_full | 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
title_fullStr | 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
title_full_unstemmed | 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
title_short | 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
title_sort | 血液透析成功解救mthfr c677t基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 |
topic | 病例报告 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295620/ https://www.ncbi.nlm.nih.gov/pubmed/34384163 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.016 |
work_keys_str_mv | AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì |